Skip to main content
. 2023 Jan 31;4(3):346–351. doi: 10.1002/bco2.210

TABLE 2.

Univariate and multivariate analysis of clinical variables

Clinical variable OR (95% CI) p value
Univariate analysis
PSA
PSA < 10 Reference
PSA 10.1–19.9 1.80 (0.11–12.65) 0.046
PSA 20–49.9 2.95 (1.53–29.23) 0.002
PSA > 50 28.02 (7.16–98.31) <0.001
T stage
Organ confined Reference
Locally advanced 8.54 (2.31–14.24) <0.001
Gleason score
G < 7 Reference
G 3 + 4 5.49 (2.74–68.43) 0.031
G 4 + 3 12.84 (5.18–94.71) <0.001
G ≥ 8 25.72 (6.42–122.16) <0.001
Multivariate analysis
PSA
PSA < 10 Reference
PSA 10.1–19.9 1.1 (0.18–6.31) 0.62
PSA 20–49.9 2.08 (0.98–14.17) 0.042
PSA > 50 16.52 (5.56–78.31) <0.001
T stage
Organ confined Reference
Locally advanced 6.02 (4.21–139.51) <0.001
Gleason score
G < 7 Reference
G 3 + 4 2.04 (0.32–16.47) 0.0511
G 4 + 3 4.7 (2.75–32.11) 0.029
G ≥ 8 11.32 (3.22–65.75) <0.001